Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec:196:432-434.
doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection

Mattia Trunfio  1 , Elena Salvador  2 , Daniela Cabodi  3 , Letizia Marinaro  2 , Chiara Alcantarini  2 , Alberto Gaviraghi  2 , Alice Trentalange  2 , Filippo Lipani  2 , Savino Sciascia  4 , Dario Roccatello  4 , Stefano Bonora  2 , Giovanni Di Perri  2 , Andrea Calcagno  2 ; e-COVID Study group
Affiliations

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection

Mattia Trunfio et al. Thromb Res. 2020 Dec.
No abstract available

Keywords: Activated factor X; COVID-19; Clinical outcome; Heparin, low molecular weight heparin, and related compounds; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

    1. Klok F.A., Kruip M.J.H.A., van der Meer N.J.M. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb. Res. 2020;191:148–150. doi: 10.1016/j.thromres.2020.04.041. - DOI - PMC - PubMed
    1. Dutt T., Simcox D., Downey C. Thromboprophylaxis in COVID-19: anti-FXa - the missing factor? Am. J. Respir. Crit. Care Med. June 8, 2020 doi: 10.1164/rccm.202005-1654LE. Published online. - DOI - PMC - PubMed
    1. White D., MacDonald S., Bull T. Heparin resistance in COVID-19 patients in the intensive care unit. J. Thromb. Thrombolysis. May 22, 2020 doi: 10.1007/s11239-020-02145-0. Published online. - DOI - PMC - PubMed
    1. Levi M., Thachil J., Iba T., Levy J.H. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440. doi: 10.1016/S2352-3026(20)30145-9. - DOI - PMC - PubMed
    1. Beun R., Kusadasi N., Sikma M., Westerink J., Huisman A. Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2. Int. J. Lab. Hematol. April 20, 2020 doi: 10.1111/ijlh.13230. Published online. - DOI - PMC - PubMed

MeSH terms